Inspire Medical Systems Cash on Hand 2017-2024 | INSP

Inspire Medical Systems cash on hand from 2017 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Inspire Medical Systems Annual Cash on Hand
(Millions of US $)
2023 $460
2022 $451
2021 $214
2020 $234
2019 $149
2018 $188
2017 $16
2016 $
Inspire Medical Systems Quarterly Cash on Hand
(Millions of US $)
2024-03-31 $441
2023-12-31 $460
2023-09-30 $464
2023-06-30 $467
2023-03-31 $452
2022-12-31 $451
2022-09-30 $428
2022-06-30 $196
2022-03-31 $203
2021-12-31 $214
2021-09-30 $210
2021-06-30 $208
2021-03-31 $226
2020-12-31 $234
2020-09-30 $235
2020-06-30 $243
2020-03-31 $136
2019-12-31 $149
2019-09-30 $152
2019-06-30 $159
2019-03-31 $177
2018-12-31 $188
2018-09-30 $120
2018-06-30 $124
2018-03-31 $18
2017-12-31 $16
2017-09-30
2017-06-30
2017-03-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.986B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.069B 20.90
Axonics (AXNX) United States $3.440B 0.00
10x Genomics (TXG) United States $3.097B 0.00
IRhythm Technologies (IRTC) United States $3.080B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.900B 0.00
Azenta (AZTA) United States $2.877B 156.36
Enovis (ENOV) United States $2.801B 20.76
Hims & Hers Health (HIMS) United States $2.633B 0.00
Privia Health (PRVA) United States $2.132B 119.80
Schrodinger (SDGR) United States $1.644B 0.00
Omnicell (OMCL) United States $1.383B 47.81
Phreesia (PHR) United States $1.205B 0.00
Standard BioTools (LAB) United States $0.696B 0.00
Fulgent Genetics (FLGT) United States $0.651B 0.00
Definitive Healthcare (DH) United States $0.627B 0.00
Talkspace (TALK) United States $0.477B 0.00
Clover Health Investments (CLOV) United States $0.406B 0.00
Health Catalyst (HCAT) United States $0.378B 0.00
Pulmonx (LUNG) United States $0.326B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.306B 0.00
Butterfly Network (BFLY) United States $0.215B 0.00
P3 Health Partners (PIII) United States $0.212B 0.00
Outset Medical (OM) United States $0.159B 0.00
American Well (AMWL) United States $0.139B 0.00
TruBridge (TBRG) United States $0.129B 7.07
MSP Recovery (LIFW) United States $0.121B 0.00
Augmedix (AUGX) United States $0.109B 0.00
111 (YI) China $0.095B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.078B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.055B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Movano (MOVE) United States $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.021B 0.00
Cue Health (HLTH) United States $0.021B 0.00
CareCloud (CCLD) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00